Ending Dry Eye by Addressing Its Root Cause
Meibum Scientific addresses the biological mechanism driving chronic dry eye disease through a protocolized platform that removes intraglandular biofilm — the missing treatment target in meibomian gland dysfunction.
Dry Eye Is a Disease of Gland Failure
Chronic dry eye is driven primarily by meibomian gland dysfunction (MGD), a progressive condition in which obstruction and inflammation impair the eye’s ability to produce a stable tear film.
Why Current Therapies Fail
Why Current Therapies Fail
Temporary relief persists while gland damage continues.
Temporary relief persists while gland damage continues.
Drops and hygiene
Lubricate the ocular surface but do not address gland obstruction.
Drops and hygiene
Lubricate the ocular surface but do not address gland obstruction.
Drops and hygiene
Lubricate the ocular surface but do not address gland obstruction.
Heat, expression, and IPL
May provide transient symptomatic relief without removing adherent intraglandular pathology.
Heat, expression, and IPL
May provide transient symptomatic relief without removing adherent intraglandular pathology.
Heat, expression, and IPL
May provide transient symptomatic relief without removing adherent intraglandular pathology.
Pharmaceuticals
Reduce inflammation but do not penetrate or remove intraglandular biofilm.
Pharmaceuticals
Reduce inflammation but do not penetrate or remove intraglandular biofilm.
Pharmaceuticals
Reduce inflammation but do not penetrate or remove intraglandular biofilm.
An Unmet Need
An Unmet Need
01
Dry eye disease
Dry eye disease (DED) affects millions globally and is one of the leading reasons for eye care visits.
01
Dry eye disease
Dry eye disease (DED) affects millions globally and is one of the leading reasons for eye care visits.
01
Dry eye disease
Dry eye disease (DED) affects millions globally and is one of the leading reasons for eye care visits.
02
95% of DED
Up to approximately 85–95% of dry eye cases are associated with meibomian gland dysfunction (MGD), contributing to persistent symptoms such as irritation, burning, blurred vision, and discomfort.
02
95% of DED
Up to approximately 85–95% of dry eye cases are associated with meibomian gland dysfunction (MGD), contributing to persistent symptoms such as irritation, burning, blurred vision, and discomfort.
02
95% of DED
Up to approximately 85–95% of dry eye cases are associated with meibomian gland dysfunction (MGD), contributing to persistent symptoms such as irritation, burning, blurred vision, and discomfort.
03
Symptom management
Current market solutions focus primarily on symptom management rather than eliminating the underlying cause of disease progression.
03
Symptom management
Current market solutions focus primarily on symptom management rather than eliminating the underlying cause of disease progression.
03
Symptom management
Current market solutions focus primarily on symptom management rather than eliminating the underlying cause of disease progression.
Dry Eye Is a Disease of Gland Failure